Navigation Links
Actress and Mother Jennifer Garner Kicks Off American Lung Association's Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
Date:11/12/2007

orman Edelman, MD, Chief Medical Officer of the American Lung Association. "The American Lung Association is pleased that Jennifer Garner has joined us to encourage people to seek influenza immunization for themselves and their families and to encourage vaccination throughout the fall and winter months, and even into the spring to help ensure they are protected."

Garner was joined today by numerous health officials and other Faces of Influenza, including: Bernadette Toomey (American Lung Association's Chief Executive Officer), Norman Edelman, MD (American Lung Association's Chief Medical Officer), actor and father Dean Cain, Anne Schuchat, MD (Centers for Disease Control and Prevention), Richard and Alissa Kanowitz (who lost their 4-year-old daughter Amanda to influenza), Tyra Bryant-Stephens, MD (Children's Hospital of Philadelphia), Luis Rodriguez, MD (Mount Sinai Services, Elmhurst Hospital Center), nurse Lori Diaz (Clinical Nurse Supervisor for the Suffolk County Department of Health in New York), as well as state and local public health officials.

About Influenza

Influenza is a serious respiratory illness that, along with its complications, kills an average of 36,000 Americans and puts approximately 226,000 in the hospital each year. The CDC recommends annual influenza vaccination for anyone wishing to reduce the risk of this disease or spreading it to others. Other target groups include: adults and children with a chronic medical condition, such as asthma, COPD and diabetes, people 50 years of age and older, pregnant women and children 6-59 months of age, residents of nursing homes and other chronic-care facilities, as well as household contacts and caregivers which includes health-care providers, babysitters and others.

Faces of Influenza Awareness Activities

The Faces of Influenza initiative will conduct widespread awareness activities during the influenza season, including national distribution of new television and radio publi
'/>"/>

SOURCE American Lung Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
9. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)....J., Nov. 21 Ikaria Holdings, Inc....mpany of the Year by the New Jersey Technology Cou...n that provides business support, networking oppor...companies and their leaders. Ikaria earned the awa...nd unique product/service provision. , , "W...
(Date:11/20/2008)... , , PHILADELPHIA, Nov. 20 /PRNewswire-Fi...nounced that the United States Food and Drug Admin...ROMACTA(R) (eltrombopag) for the treatment of thro...pathic) thrombocytopenic purpura (ITP) who have ha...unoglobulins or splenectomy. The approval is a sig...
(Date:11/20/2008)..., Calif., Nov. 20 Bionov...ill present results from the Phase 1B,clinical tr...static breast,cancer, BZL101, at the Society for ...ence in Atlanta, Georgia. The Company,s oral pres...nd will be presented as a part of the Best of the,...
(Date:11/20/2008)...v. 20 PAREXEL Internatio...l biopharmaceutical services provider, today annou... provide regulatory consulting and clinical resear...ice, PAREXEL now has locations throughout five imp... which also include Argentina, Brazil, Chile, and ...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva 28TM 29 9941 1KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva 28TM 29 9941 2KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva 28TM 29 9941 3KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva 28TM 29 9941 4KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva 28TM 29 9941 5LOGICARE Selects M2SYS Biometric Fingerprint Software to Ensure Patient Privacy and Protect Confidential Information 1988 1LOGICARE Selects M2SYS Biometric Fingerprint Software to Ensure Patient Privacy and Protect Confidential Information 1988 2DNA sensors found to be an effective artificial nose 2696 1Stroke Undertreated 9939 1Stroke Undertreated 9939 2Stroke Undertreated 9939 3
...od and Drug,Administration (FDA) today issued the ...nitiatives/criticalpath/reports/generic.html">Crit... identifying many,of the unanswered scientific que...ions of commonly used drugs. , The report is part ...2004 to discern what challenges exist in moving a,...
...eNeS Pharmaceuticals plc,(LSE: CEN), the Cambridge...that the United States Food and Drug Administratio...(IND) application for the,clinical development of ...he treatment of post-operative pain. Earlier this ... of M6G in Europe in,over 500 patients with post-o...
Other Medicine Technology:New Critical Path Report Highlights Research Needed to Foster,Generic Drug Development 2FDA approves IND on Lead Product M6G 2
(Date:11/21/2008)...als showed Banzel proved effective against Lennox-...althDay News) -- A new drug called Banzel (rufinam...t for a severe form of epilepsy called Lennox-Gast...n announced Friday. , The approval was based on...ded patients ages 4 to 30. Compared to patients wh...
(Date:11/21/2008)...LADELPHIA, Nov. 21 NursingCenter.c...g education and peer reviewed content, has been,u...ts 350,000 registered,users. Powered by Lippincot...now,provides over 900 peer-reviewed continuing ed...cles from more than 50 leading nursing journals.,...
(Date:11/21/2008)...NKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCall/ ...for medical intervention in treating 88 percent of...rcent of Americans treated for a chronic condition...pending and 75 percent of all medical costs. A pr...years by Medco Health Solutions, Inc. (NYSE: MHS...
(Date:11/21/2008)...n 430 B.C., a new and deadly diseaseits cause rema...ity-state was teeming with citizens, soldiers and ... Sparta. As streets filled with corpses, social or...ness returned twice and Athens lost a third of its...hens marked the beginning of the end of the Golden...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...confirmed a link between exercising and the preven...a study conducted researchers gathered results fro...0 to 69. Participants were asked about the level o...ent and adult years.Results show women who exercis...
...hat a few alcoholic beverages a month may reduce t...n // with high blood pressure. Researchers found w...ificantly lower risk of death by nearly 30 percent... also a reduced risk of cardiovascular disease dea...
... survival rate of breast cancer patients by 63 per...rd regimes available . The clinical trial strength...mestane, as a first option.// A study showed that ... chance of developing another tumor by 32 percent ...
...lition of Health for Asthmatics in Sports and Exer...ave an exercise test // to 127, 6- to 18-year ol...sk factors were determined by a 10-item questionna...n was a family member having allergies or asthma. ...
Other Medicine News:
...cal IOL is a foldable silicone IOL. It features a ...e inserted with The UNFOLDER® Silver-T Implant... first and only FDA-approved multifocal IOL, and t...nal visionnear, intermediate, and far. The ARRAY&r...
...ferred viscoelastic for phacoemulsification proced...rks from the start to the finish of the case. The ...lastic is the reason. The low to moderate vacuum f...nly a fraction of the viscoelastic agent. However,...
...scoelastic agent for the surgeon who performs cata... Amvisc possesses sufficient viscosity for excelle... is highly cohesive so that complete removal at th...ed. Amvisc is priced to compete with any sodium hy...
...onate (1.8%) viscoelastic solution combines maximu...flo maintains a deep anterior chamber and protects... ideal for routine cataract surgery but can be use...lastic. Combine all these properties with the conv...
Medicine Products: